National Institutes of Health: Hypertriglyceridemia trials

The registry lists 13 Hypertriglyceridemia studies with National Institutes of Health as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 3Phase 3 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic HyperlipidemiaNot yet recruitingNCT07715890Not applicable
• Genes Involved in Lipid DisordersCompletedNCT02311335
• Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyActive, not recruitingNCT02262832Phase 3
• Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyActive, not recruitingNCT02262806Phase 2
• The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy VolunteersCompletedNCT01148004Phase 1
• Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIVCompletedNCT00246402Not applicable
• Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug TherapyCompletedNCT00109603Not applicable
• The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)CompletedNCT00076518Phase 2
• Genetic Determinants:Low HDL, High Triglycerides, ObesityCompletedNCT00049881
• Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected PatientsCompletedNCT00046267Not applicable
• Garlic in Hyperlipidemia Caused by HAARTWithdrawnNCT00029250Phase 2
• Rosiglitazone and Exercise Training: Effects on HIV-Infected People With Insulin Resistance, Hypertriglyceridemia, and Adipose Tissue MaldistributionCompletedNCT00025753Not applicable
• Re-evaluating Triglycerides in Coronary Heart DiseaseCompletedNCT00005442